Plain-English translation of NCT04985032 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a newer type of radiation therapy called stereotactic body radiation therapy (SBRT) for women with early-stage breast cancer. Instead of the traditional weeks-long radiation treatment, SBRT delivers focused, high-dose radiation to just the area where the tumor was removed. The goal is to see if this faster approach works just as well while being more convenient for patients.
Traditional breast radiation takes several weeks and can be inconvenient for patients. Researchers want to know if this newer, faster radiation method is safe and effective, potentially reducing treatment time while maintaining excellent outcomes.
You likely qualify if…
You likely don't qualify if…
You will have small gold markers (fiducials) placed in your breast during or after your surgery to help guide the radiation. Before treatment begins, you'll undergo CT scans and possibly other imaging to map out exactly where the radiation should go. Then you'll receive several focused radiation treatments over a short period of time, either on a linear accelerator or a robotic system called CyberKnife, with careful positioning and monitoring during each session.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States